9969.HK Current Ratio

The Current Ratio of InnoCare Pharma Ltd (9969.HK) is 19.49.

Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.

9969.HK Current Ratio - Historical Value

Date	Value
2021-12-31	19.49
2020-12-31	39.18
2019-12-31	36.68
2018-12-31	28.55
2017-12-31	0.51

9969.HK Current Ratio - Peers Comparison

Ticker	Name	Value
300406.SZ	Beijing Strong Biotechnologies Inc	9.28
600201.SS	Jinyu Bio-Technology Co Ltd	3.02
1530.HK	3SBio Inc	1.71
300294.SZ	China Resources Boya Bio pharmaceutical Group Co Ltd	6.74
688488.SS	Jiangsu Aidea Pharmaceutical Co Ltd	1.38
000403.SZ	Pacific Shuanglin Bio-pharmacy Co Ltd	3.74
002030.SZ	Daan Gene Co Ltd	2.92
002675.SZ	Yantai Dongcheng Biochemicals Co Ltd	1.46
002880.SZ	Shenzhen Weiguang Biological Products Co Ltd	3.61
600645.SS	Vcanbio Cell & Gene Engineering Corp Ltd	1.65
688298.SS	Zhejiang Orient Gene Biotech Co Ltd	3.31
688278.SS	Xiamen Amoytop Biotech Co Ltd	4.34
002038.SZ	Beijing SL Pharmaceutical Co Ltd	8.60
2616.HK	CStone Pharmaceuticals	1.60
300685.SZ	Amoy Diagnostics Co Ltd	9.18
300832.SZ	Shenzhen New Industries Biomedical Engineering Co Ltd	5.56
688336.SS	Sunshine Guojian Pharmaceutical Shanghai Co Ltd	8.39
2696.HK	Shanghai Henlius Biotech Inc	0.50
300009.SZ	Anhui Anke Biotechnology Group Co Ltd	3.41
300841.SZ	Chengdu Kanghua Biological Products Co Ltd	4.39
600161.SS	Beijing Tiantan Biological Products Corp Ltd	6.89
002022.SZ	Shanghai Kehua Bio-Engineering Co Ltd	3.46
1952.HK	Everest Medicines Ltd	8.36
688198.SS	Beijing Balance Medical Technology Co Ltd	5.17
300639.SZ	Guangdong Hybribio Biotech Co Ltd	5.04
603387.SS	Getein Biotech Inc	2.20
688136.SS	Kexing Biopharm Co Ltd	1.45
688166.SS	BrightGene Bio-Medical Technology Co Ltd	1.56